| Dr Scott A Schroeder, DPM | |
|
616 N Chelan Ave, Wenatchee, WA 98801-2025 | |
| (509) 662-2970 | |
| (509) 665-9808 |
| Full Name | Dr Scott A Schroeder |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 616 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124054911 | NPI | - | NPPES |
| CS9149 | Other | WA | PALMETTO GBA RAILROAD MEDICARE PART B |
| 0035677 | Other | WA | WA STATE LABOR AND INDUSTRY |
| 1057256 | Medicaid | WA | |
| 480015509 | Other | WA | PALMETTO GBA - RAILROAD MEDICARE |
| Provider Name | Foot & Ankle Center Of Wenatchee, P.s. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114146263 PECOS PAC ID: 2365333879 Enrollment ID: O20040402000882 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
A study by researchers at Yale has uncovered why belly fat surrounding organs increases as people age, a finding that could offer new treatment possibilities for improving metabolic health, thereby reducing the likelihood for diseases like diabetes and atherosclerosis that stem from inflammation.
The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million.
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott A Schroeder, DPM 616 N Chelan Ave, Wenatchee, WA 98801-2025 Ph: (509) 662-2970 | Dr Scott A Schroeder, DPM 616 N Chelan Ave, Wenatchee, WA 98801-2025 Ph: (509) 662-2970 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
A study by researchers at Yale has uncovered why belly fat surrounding organs increases as people age, a finding that could offer new treatment possibilities for improving metabolic health, thereby reducing the likelihood for diseases like diabetes and atherosclerosis that stem from inflammation.
The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million.
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
Foot & Ankle Center Of Wenatchee, P.s. Podiatrist Medicare: Medicare Enrolled Practice Location: 616 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-2970 Fax: 509-665-9808 | |
Dr. Joel D. Hix, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Tony D. H. Kim, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 616 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-2970 Fax: 509-665-9808 | |
Brandon J Child, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Jac R Tiechner, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 616 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-2970 Fax: 509-665-9808 | |
Marjorie Rarama, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |